Eric Hsu is a corporate and securities partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati. He represents emerging growth companies in areas such as medical devices, digital health, and biotechnology. Eric advises public and private companies on general corporate matters, mergers and acquisitions, initial public offerings, public company reporting, strategic partnerships, venture capital financings, and private equity and debt financings.

Dr. Ingo Hardt is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he assists with the preparation and prosecution of patent applications in the fields of chemistry, pharmaceuticals, and biotechnology. He has been a registered patent agent since 2003.

Marty represents innovative life sciences and technology clients in corporate transactions and governance matters.

Bu Yin is senior counsel in the San Diego office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on developing patent portfolios and providing strategic counseling in pharmaceuticals (particularly biologics), biotech tools (e.g., genomics, transcriptomics, and proteomics), agriculture and food (e.g., genetically modified insects as biopesticides), and other life sciences sectors.